Factors affecting discharge status of hospitalized myasthenia gravis patients (N=936).
| Variable | Discharge Status | P-value | |||
|---|---|---|---|---|---|
| Improved | Not improved | Dead | Total | ||
| n (%) | |||||
| Gender | 0.399 | ||||
| Male | 242 (91.0) | 21 (7.9) | 3 (1.1) | 266 (28.4) | |
| Female | 603 (90.0) | 50 (7.5) | 17 (2.5) | 670 (71.6) | |
| Age | 0.072 | ||||
| 18-29 | 138 (91.4) | 12 (7.9) | 1 (0.7) | 151 (16.1) | |
| 30-39 | 201 (91.8) | 16 (7.3) | 2 (0.9) | 219 (23.4) | |
| 40-49 | 204 (89.1) | 22 (9.6) | 3 (1.3) | 229 (24.5) | |
| 50-59 | 177 (90.3) | 14 (7.1) | 5 (2.6) | 196 (20.9) | |
| 60-69 | 93 (89.4) | 5 (4.8) | 6 (5.8) | 104 (11.1) | |
| 70-79 | 23 (88.5) | 1 (3.8) | 2 (7.7) | 26 (2.8) | |
| 80+ | 9 (81.8) | 1 (9.1) | 1 (9.1) | 11 (1.2) | |
| Insurance groups | 0.040 | ||||
| Government welfare | 95 (90.5) | 6 (5.7) | 4 (3.8) | 105 (11.2) | |
| Social welfare | 183 (95.3) | 7 (3.6) | 2 (1.0) | 192 (20.5) | |
| Universal coverage | 567 (88.7) | 58 (9.1) | 14 (2.2) | 639 (68.3) | |
| Hospital category | <0.001 | ||||
| Primary | 72 (72.0) | 27 (27.0) | 1 (1.0) | 100 (11.0) | |
| Secondary | 175 (87.1) | 22 (10.9) | 4 (2.0) | 201 (21.0) | |
| Tertiary | 491 (94.2) | 18 (3.5) | 12 (2.3) | 521 (56.0) | |
| Private | 107 (93.9) | 4 (3.5) | 3 (2.6) | 114 (12.0) | |
| Regions | <0.001 | ||||
| Northern | 197 (89.5) | 19 (8.6) | 4 (1.8) | 220 (23.5) | |
| Northeast | 240 (87.0) | 34 (12.3) | 2 (0.7) | 276 (29.5) | |
| Central | 367 (93.9) | 11 (2.8) | 13 (3.3) | 391 (41.8) | |
| Southern | 41 (83.7) | 7 (14.3) | 1 (2.0) | 49 (5.2) | |
| Pneumonia | <0.001 | ||||
| No | 778 (92.0) | 56 (6.6) | 12 (1.4) | 846 (90.4) | |
| Yes | 67 (74.4) | 15 (16.7) | 8 (8.9) | 90 (9.6) | |
| Respiratory failure | <0.001 | ||||
| No | 660 (94.0) | 41 (5.8) | 1 (0.1) | 702 (75.0) | |
| Yes | 185 (79.1) | 30 (12.8) | 19 (8.1) | 234 (25.0) | |
| Intravenous immunoglobins | 0.999 | ||||
| No | 840 (90.2) | 71 (7.6) | 20 (2.1) | 931 (99.5) | |
| Yes | 5 (100.0) | 0 (0.0) | 0 (0.0) | 5 (0.5) | |